Skip to main content
. 2015 Oct 13;36(12):1531–1538. doi: 10.1093/carcin/bgv149

Table 1.

Bulky DNA adducts and oxidative DNA damage in the lung of A/J mice, as related to exposure to ECS and/or treatment with either AsA or naproxen

Treatment Gender DNA adducts/108 nucleotides
(means ± SE)
8-oxo-dGuo/105 nucleotides
(means ± SE)
Sham M 2.0±0.16 1.7±0.16
F 1.7±0.18 1.5±0.16
M + F 1.9±0.12 1.6±1.09
AsA M 1.5±0.32 1.4±0.12
F 1.5±0.21 1.3±0.10
M + F 1.5±0.18 1.4±0.08
Naproxen M 1.9±0.15 1.5±0.16
F 1.9±0.20 1.3±0.09
M + F 1.9±0.12 1.4±0.09
ECS M 15.8±0.95a 5.8±0.28b
F 16.6±0.84a 5.8±0.37b
M + F 16.2±0.61a 5.8±0.22b
ECS + AsA M 7.3±0.59a,d 3.2±0.33b,d
F 8.0±1.06a,d 3.7±0.68b,c
M + F 7.5±0.99a,d 3.4±0.34b,d
ECS + Naproxen M 6.5±0.53a,d 3.1±0.52b,c
F 7.4±1.09a,d 4.0±0.43b,d
M + F 7.0±0.59a,d 3.6±0.35b,d

The lungs of 10 mice per experimental group (five males and five females) were examined at the age of 10 weeks.

Statistical analysis: a P < 0.01 and b P < 0.001, as compared with the corresponding Sham; c P < 0.01 and d P < 0.001, as compared with the corresponding ECS.